QQ客服 官方微博 反馈留言

	Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
	Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Tan Z; Wang J; Zhang Y.
刊名	Oncotarget
	2016
关键词	Akt PUMA apoptosis colon cancer p53
ISSN号	0043-8790
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6067215
专题	湖南大学
作者单位	1.College of Biology, Hunan University, Changsha, China. 2.Department of Laboratory Medicine, Xiangya School of Medicine, Department of Internal Medicine, Outpatient Building, The Third Xiangya Hospital, Central South University, Changsha, China. 3.School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. 4.Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, China. 5.Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China. 6.Shenzhen Institute, Hunan University, Shenzhen, China.
推荐引用方式 GB/T 7714	Zhang L,Wang H,Li W,et al. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.[J]. Oncotarget,2016.
APA	Zhang L.,Wang H.,Li W.,Zhong J.,Yu R.,...&Zhang Y..(2016).Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis..Oncotarget.
MLA	Zhang L,et al."Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.".Oncotarget (2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。